As expected, we found that UA could remarkably shrink the tumor volume and reduced spontaneous hepatocellular carcinogenesis via inhibiting PI3K/Akt signaling, and then be employed as a novel strategy for HCC treatment. Here, AKT1 is linked to hepatocellular carcinoma.